Hospital-Based Management of Patients With Chronic Hepatitis B Virus Infection
Launched by THIRD AFFILIATED HOSPITAL, SUN YAT-SEN UNIVERSITY · May 11, 2025
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The "Hot wave Project" aims to establish a multicenter management cohort for HBsAg-positive patients within hospitals. Led by infectious disease specialists, the program conducts regular hepatitis B training sessions for hospital staff to enhance their understanding of HBV prevention and control. This initiative seeks to increase HBsAg screening rates overall and encourage patients from non-infectious disease departments to seek referrals to specialized care.
For all paper reports containing HBsAg test results, a remark is added stating: "HBsAg (+) - Recommended to visit the Hepatitis B He...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • HBsAg-positive patients attending non-infectious disease/hepatology departments at three study centers between January 2025 and December 2025.
- Exclusion Criteria:
- • HBsAg-positive patients already under regular follow-up in infectious disease/hepatology clinics.
- • Chronic HBV patients on regular antiviral treatment.
About Third Affiliated Hospital, Sun Yat Sen University
The Third Affiliated Hospital of Sun Yat-sen University is a leading medical institution in China, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, the hospital leverages its comprehensive resources and multidisciplinary expertise to facilitate cutting-edge studies that aim to improve patient outcomes and contribute to the global body of medical knowledge. With a focus on collaboration and patient-centered care, the Third Affiliated Hospital is dedicated to fostering advancements in medical science and ensuring the highest standards of ethical practice in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Guangzhou, Guangdong, China
Zhuhai, Guangdong, China
Guangzhou, Guangdong, China
Patients applied
Trial Officials
Liang Peng
Principal Investigator
Third Affiliated Hospital, Sun Yat-Sen University
Zhongsi Hong
Principal Investigator
Fifth Affiliated Hospital, Sun Yat-Sen University
Fangfang Wei
Principal Investigator
Sixth Affiliated Hospital, Sun Yat-sen University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported